Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.00082 | 1 |
mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.0029 | 1 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |